Integra LifeSciences (Nasdaq:IART) announced today that it completed its acquisition of Surgical Innovation Associates (SIA). Princeton, New Jersey-based Integra announced that it agreed to acquire SIA last week. SIA develops, markets and sells the DuraSorb resorbable synthetic matrix for plastic and reconstruction surgery. Integra believes the acquisition advances its global strategy in breast reconstruction. The deal expands […]
Surgical Innovation Associates
Integra LifeSciences to acquire Surgical Innovation Associates
Integra LifeSciences (Nasdaq:IART) announced today that it entered into a definitive agreement to acquire Surgical Innovation Associates (SIA). SIA develops, markets and sells the DuraSorb resorbable synthetic matrix for plastic and reconstruction surgery. Princeton, New Jersey–based Integra said in a news release that the acquisition advances its global strategy in breast reconstruction. The deal expands […]
Surgical Innovation Associates gains CE Mark for absorbable mesh
Surgical Innovation Associates announced this week that it has secured CE Mark approval for its flagship absorbable mesh, DuraSorb. The product is designed to provide mechanical support and scaffolding during the early months of wound healing and scar formation, followed by gradual absorption to leave the patient free of foreign material by one year, according to […]